期刊文献+

慢性HBV感染者血清维生素D水平及其临床意义 被引量:11

Clinical study of serum vitamin D in chronic HBV infected patients
下载PDF
导出
摘要 目的检测不同疾病状态慢性HBV感染者的血清25(OH)D水平,并探讨其临床意义。方法收集慢性HBV感染者246例(慢性乙型肝炎患者90例,乙肝肝硬化代偿期患者70例,乙肝肝硬化失代偿期患者86例),80例健康体检者为对照,检测所有患者的血清25(OH)D水平、肝功、凝血及乙肝病毒学标志物并对肝硬化患者进行Child-Pugh分级、计算肝脏纤维化FIB-4评分等。结果①慢性HBV感染者血清25(OH)D平均水平为(14.37±7.18)ng/mL,低于正常对照组[(23.60 ± 6.20 ) ng/mL,P<0.05],其中乙肝肝硬化失代偿期患者血清25(OH)D水平[(11.20± 5.99 )ng/mL]低于慢性乙型肝炎患者[(15.22±6.84)ng/mL,P<0.001]和乙肝肝硬化代偿期患者[(17.16± 7.55)ng/mL ,P< 0.001 ],差异均有统计学意义;②血清25(OH)D与ALB水平均呈正相关,与PT水平呈负相关,肝硬化患者的血清25(OH)D水平与FIB-4评分呈负相关;③在肝硬化Child-Pugh C级的患者中血清25(OH)D缺乏者占91.9%,Child-Pugh B级的患者中血清25(OH)D缺乏者占81.6%,Child-Pugh A级的患者中血清25(OH)D缺乏者占67.1%;④单因素及多因素 Logistic 回归分析结果提示,FIB-4评分≥1.45的慢性乙型肝炎患者,发生肝硬化代偿的可能性大;血清25(OH)D水平<20 ng/mL的肝硬化代偿期患者,发生肝硬化失代偿的可能性大,肝脏病变程度重。结论维生素D缺乏在慢性HBV感染者中普遍存在,肝硬化失代偿患者尤为显著;血清维生素D水平可作为评估慢性HBV感染者疾病严重程度的指标之一。 Objective To assess the level of serum 25(OH)D in patients infected with chronic hepatitis B virus (HBV) at different stages so as to explore their clinical significance. Methods We quantified the levels of serum 25(OH)D from 246 chronic HBV-infected patients (chronic hepatitis B, n =90;compensated liver cirrhosis, n =70;and decompensated liver cirrhosis, n =86) in the study. Serum 25(OH)D level,liver function,coagulation index,and HBV markers were tested in all the patients. Child-Pugh grade and FIB-4 score of liver fibrosis were calculated in patients with liver cirrhosis. Results ① The mean serum level of vitamin D in chronic HBV infection patients was significantly lower than that in healthy controls [(14.37±7.18)ng/mL vs.(23.60±6.20)ng/mL, P <0.05]. Serum 25(OH)D level in patients with decompensated cirrhosis was obviously lower than that in patients with chronic hepatitis B [(15.22±6.84)ng/mL, P <0.001] and compensated cirrhosis [(17.16±7.55)ng/mL, P < 0.001 ].② Serum 25(OH)D had a positive correlation with ALB level,but a negative correlation with PT level. Serum 25(OH)D level in liver cirrhosis patients was significant negatively correlated with FIB-4 scores.③ Of the liver cirrhosis patients,91.9% patients in Child-Pugh C group,81.6% patients in Child-Pugh B group,and 67.1% patients in Child-Pugh A group had serum 25(OH)D level deficiency. Univariate and multivariate logistic regression analysis showed that CHB patients with FIB-4 score≥1.45 were more likely to develop compensated liver cirrhosis. Compensated liver cirrhosis patients with serum 25(OH) D level <20 ng/mL had the high possibility of decompensation cirrhosis and more severe hepatic injury. Conclusion Vitamin D deficiency is prevalent in chronic HBV-infected patients,especially in those with decompensated cirrhosis. Vitamin D level can be used as an indicator to assess the severity of chronic HBV infection.
作者 蔺淑梅 安小翠 张曦 杨雪亮 陈云茹 刘小静 叶峰 石磊 LIN Shu-mei;AN Xiao-cui;ZHANG Xi;YANG Xue-liang;CHEN Yun-ru;LIU Xiao-jing;YE Feng;SHI Lei(Department of Infectious Diseases,The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China)
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2019年第6期937-941,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 国家艾滋病和病毒性肝炎等重大传染病防治科技专项课题(No.2017ZX10201201,No.2017ZX10202202) 陕西省自然科学基础研究计划(No.2017JM8083) 陕西省社会发展科技攻关课题(No.2015SF069)~~
关键词 维生素D 乙型肝炎病毒 慢性肝脏疾病 肝脏纤维化 肝硬化 vitamin D hepatitis B virus chronic hepatitis disease liver fibrosis cirrhosis
  • 相关文献

参考文献2

二级参考文献14

  • 1Edmondo Falleti,Davide Bitetto,Carlo Fabris,Annarosa Cussigh,Elisabetta Fontanini,Ezio Fornasiere,Elisa Fumolo,Sara Bignulin,Sara Cmet,Rosalba Minisini,Mario Pirisi,Pierluigi Toniutto.Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis[J].World Journal of Gastroenterology,2010,16(24):3016-3024. 被引量:14
  • 2S. Yokoyama,S. Takahashi,Y. Kawakami,C. N. Hayes,H. Kohno,H. Kohno,K. Tsuji,Y. Aisaka,S. Kira,K. Yamashina,M. Nonaka,T. Moriya,M. Kitamoto,S. Aimitsu,T. Nakanishi,H. Kawakami,K. Chayama.Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial[J].J Viral Hepat.2014(5)
  • 3Eric Trépo,Romy Ouziel,Pierre Pradat,Yukihide Momozawa,Eric Quertinmont,Christine Gervy,Thierry Gustot,Delphine Degré,Vincent Vercruysse,Pierre Deltenre,Laurine Verset,Beatrice Gulbis,Denis Franchimont,Jacques Devière,Arnaud Lemmers,Christophe Moreno.Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease&lt;!-- Doctopic: GMD --&gt;[J].Journal of Hepatology.2013(2)
  • 4Sérgio Bucharles,Silvio Henrique Barberato,Andréa E.M. Stinghen,Betina Gruber,Luciana Piekala,Ana Cláudia Dambiski,Melani R. Custodio,Roberto Pecoits-Filho.Impact of Cholecalciferol Treatment on Biomarkers of Inflammation and Myocardial Structure in Hemodialysis Patients Without Hyperparathyroidism[J].Journal of Renal Nutrition.2012(2)
  • 5Ansar A. Khan,Edwin C.Y. Chow,Anne-miek M.A. van Loenen-Weemaes,Robert J. Porte,K. Sandy Pang,Geny M.M. Groothuis.Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver[J].European Journal of Pharmaceutical Sciences.2009(2)
  • 6Emilie D’Aldebert,Marie–Jeanne Biyeyeme Bi Mve,Martine Mergey,Dominique Wendum,Delphine Firrincieli,Audrey Coilly,Laura Fouassier,Christophe Corpechot,Raoul Poupon,Chantal Housset,Nicolas Chignard.Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium[J].Gastroenterology.2009(4)
  • 7Atsushi Tanaka,Saeko Nezu,Satoko Uegaki,Kentaro Kikuchi,Akitaka Shibuya,Hiroshi Miyakawa,Shin-ichi Takahashi,Ilaria Bianchi,Paola Zermiani,Mauro Podda,Hiromasa Ohira,Pietro Invernizzi,Hajime Takikawa.Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations[J].Journal of Hepatology.2009(6)
  • 8Whitney S. Goldner,Julie A. Stoner,Jon Thompson,Karen Taylor,Luann Larson,Judi Erickson,Corrigan McBride.Prevalence of Vitamin D Insufficiency and Deficiency in Morbidly Obese Patients: A Comparison with Non-Obese Controls[J].Obesity Surgery.2008(2)
  • 9Janus P. Ong,Zobair M. Younossi.Epidemiology and Natural History of NAFLD and NASH[J].Clinics in Liver Disease.2007(1)
  • 10Giovanni Targher,Lorenzo Bertolini,Luca Scala,Massimo Cigolini,Luciano Zenari,Giancarlo Falezza,Guido Arcaro.Associations between serum 25-hydroxyvitamin D 3 concentrations and liver histology in patients with non-alcoholic fatty liver disease[J].Nutrition Metabolism and Cardiovascular Diseases.2006(7)

共引文献43

同被引文献132

引证文献11

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部